These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25585601)

  • 1. The influence of body mass index on the accumulation of advanced glycation end products in hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Eur J Clin Nutr; 2015 Mar; 69(3):309-13. PubMed ID: 25585601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in skin autofluorescence and release of heart-type fatty acid binding protein in plasma predicts mortality of hemodialysis patients.
    Arsov S; Trajceska L; van Oeveren W; Smit AJ; Dzekova P; Stegmayr B; Sikole A; Rakhorst G; Graaff R
    Artif Organs; 2013 Jul; 37(7):E114-22. PubMed ID: 23635017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients.
    Meerwaldt R; Hartog JW; Graaff R; Huisman RJ; Links TP; den Hollander NC; Thorpe SR; Baynes JW; Navis G; Gans RO; Smit AJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3687-93. PubMed ID: 16280473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does hepatitis C increase the accumulation of advanced glycation end products in haemodialysis patients?
    Arsov S; Graaff R; Morariu AM; van Oeveren W; Smit AJ; Busletic I; Trajcevska L; Selim G; Dzekova P; Stegmayr B; Sikole A; Rakhorst G
    Nephrol Dial Transplant; 2010 Mar; 25(3):885-91. PubMed ID: 19934094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin and plasma autofluorescence during hemodialysis: a pilot study.
    Graaff R; Arsov S; Ramsauer B; Koetsier M; Sundvall N; Engels GE; Sikole A; Lundberg L; Rakhorst G; Stegmayr B
    Artif Organs; 2014 Jun; 38(6):515-8. PubMed ID: 24164288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Examination of skin autofluorescence for the determination of glycation end-products in patients on chronic hemodialysis].
    Golubev RV; Papayan GV; Glazunova AA; Korosteleva NY; Petrishchev NN; Smirnov AV
    Ter Arkh; 2016; 88(6):65-72. PubMed ID: 27296264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
    Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
    J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue advanced glycation end products (AGEs), measured by skin autofluorescence, predict mortality in peritoneal dialysis.
    Siriopol D; Hogas S; Veisa G; Mititiuc I; Volovat C; Apetrii M; Onofriescu M; Busila I; Oleniuc M; Covic A
    Int Urol Nephrol; 2015 Mar; 47(3):563-9. PubMed ID: 25425437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis.
    El-Saeed GS; Fadel F; Elshamaa MF; Galal RE; Elghoroury EA; Nasr SA; Thabet EH; Abdelrahman SM
    Ren Fail; 2015; 37(9):1452-6. PubMed ID: 26337710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
    Hartog JW; Hummel YM; Voors AA; Schalkwijk CG; Miyata T; Huisman RM; Smit AJ; Van Veldhuisen DJ
    J Card Fail; 2008 Sep; 14(7):596-602. PubMed ID: 18722326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a body mass index of 23 kg/m² a reliable marker of protein-energy wasting in hemodialysis patients?
    Leal VO; Moraes C; Stockler-Pinto MB; Lobo JC; Farage NE; Velarde LG; Fouque D; Mafra D
    Nutrition; 2012 Oct; 28(10):973-7. PubMed ID: 22503532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing changes in plasma and skin autofluorescence in low-flux versus high-flux hemodialysis.
    Ramsauer B; Engels G; Arsov S; Hadimeri H; Sikole A; Graaff R; Stegmayr B
    Int J Artif Organs; 2015 Sep; 38(9):488-93. PubMed ID: 26481293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of baseline adiponectin on all-cause mortality in hemodialysis patients depending on initial body mass index. Long-term follow-up data of 4.5 years.
    Tsigalou C; Chalikias G; Kantartzi K; Tziakas D; Kampouromiti G; Vargemezis V; Konstantinides S; Ktenidou-Kartali S; Simopoulos K; Passadakis P
    J Ren Nutr; 2013 Jan; 23(1):45-56. PubMed ID: 22406123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional parameters and mortality in incident hemodialysis patients.
    Araújo IC; Kamimura MA; Draibe SA; Canziani ME; Manfredi SR; Avesani CM; Sesso R; Cuppari L
    J Ren Nutr; 2006 Jan; 16(1):27-35. PubMed ID: 16414438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the Combination of Hemodialysis and Hemoperfusion on Clearing Advanced Glycation End Products: A Prospective, Randomized, Two-Stage Crossover Trial in Patients Under Maintenance Hemodialysis.
    Zhang Y; Mei CL; Rong S; Liu YY; Xiao GQ; Shao YH; Kong YZ
    Blood Purif; 2015; 40(2):127-32. PubMed ID: 26160062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular access modifies the protective effect of obesity on survival in hemodialysis patients.
    Arhuidese IJ; Obeid T; Hicks C; Qazi U; Botchey I; Zarkowsky DS; Reifsnyder T; Malas MB
    Surgery; 2015 Dec; 158(6):1628-34. PubMed ID: 26126794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.
    Jiang J; Chen P; Chen J; Yu X; Xie D; Mei C; Xiong F; Shi W; Zhou W; Liu X; Sun S; Zhang P; Yang X; Zhang Y; Zhang Y; Liang X; Zhang Z; Lin Q; Yu Y; Miyata T; Tian J; Liang M; Luo W; Xu X; Hou F
    Atherosclerosis; 2012 Sep; 224(1):187-94. PubMed ID: 22857897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
    Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
    Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.